Cellmid Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cellmid Limited with three other
companies in this sector in Australia:
Medlab Clinical Ltd
sales of 4.45 million Australian Dollars [US$3.37 million]
Factor Therapeutics Ltd
(4.02 million Australian Dollars [US$3.05 million]
of which 100%
was Biotechnology), and
Prima Biomed Limited
(4.22 million Australian Dollars [US$3.20 million]
of which 98%
was Cancer Immunotherapy).
Cellmid Limited reported sales of A$4.72 million (US$3.58 million)
June of 2017.
increase of 39.4%
versus 2016, when the company's sales were A$3.39 million.